DOI: 10.36347/sjams.2017.v05i11.074

Pages: 4687-4690

Metabolic disorders, such as obesity and diabetes, are significant health care concerns. Globally, an estimated 300 million adults are considered obese. Diabetes is a worldwide epidemic, expected to affect more than 366 million adults by 2030. Epidemiologic data suggest that the patients with mental illness are at a greater risk of developing metabolic disorders with diabetes and obesity estimated to be 1.5 to 2 times more common in patients with mental illness than the general population. A Lack of awareness regarding this problem can contribute to serious morbidity and mortality among patients with mental illness, especially in the form of increased cardiovascular disease risk. In recent years, treatment with atypical antipsychotics has come under scrutiny for potential adverse metabolic effects [1]. However, through increased awareness, early interventions, and cooperation among the medical community, caregivers, and patients with mental illness, the deleterious effects of comorbid metabolic disorders may be offset and the positive profile of atypical antipsychotics can be maintained. The purpose of this article is to discuss various metabolic disorders that can occur concurrently with mental illness. It will describe the effects that the disease and antipsychotic treatment can have on these disorders and focus on 4 metabolic disorders that are common in patients with mental illness, hyperprolactinemia, obesity, lipid abnormalities, and impaired glucose metabolism. Monitoring recommendations and treatment challenges in patients with mental illness and comorbid metabolic disorders also will be discussed. Psychiatrists in the next few years can anticipate dramatic shifts in the delivery of Mental Health Care. There is a lack of integration of general medical care with psychiatric care and the related problem of barrier to collaboration. Persons with SMI have elevated rates of morbidity and morality from a number of medical illnesses like CVD, obesity, type II